COVID-19 treatments.Filomena Tassi, Canada’s minister of public services and procurement, told reporters on Friday the government has signed agreements with Pfizer and Merck to buy up to 1.5 million courses of their antiviral pills, PF-07321332 and Molnupiravir.Both treatments are under Health Canada review, Tassi added.“We also know that access to effective, easy-to-use treatments is critical to reducing the severity of COVID infections and will help save lives,” she said.“As soon as these drugs are authorized for use, the government will work on getting them to provinces and territories as quickly as possible so that health-care providers can help Canadians who need them most.” Canadians 18+ should be offered COVID-19 booster 6 months.